We are live on ! Find out more
HAE icon

Haemonetics
HAE

294 hedge funds and large institutions have $3.9B invested in Haemonetics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 103 increasing their positions, 104 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 20

9% more funds holding

Funds holding: 270 → 294 (+24)

2% more capital invested

Capital invested by funds: $3.83B → $3.9B (+$73.2M)

1% less repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 104

1.32% less ownership

Funds ownership: 100.85% → 99.53% (-1.3%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

56% less call options, than puts

Call options by funds: $3.35M | Put options by funds: $7.67M

Holders
294
Holders Change
+24
Holders Change %
+8.89%
% of All Funds
4.73%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
49
Increased
103
Reduced
104
Closed
20
Calls
$3.35M
Puts
$7.67M
Net Calls
-$4.32M
Net Calls Change
-$3.84M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$48.3M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$36.5M
3
BlackRock
BlackRock
New York
+$26.9M
4
Boston Partners
Boston Partners
Massachusetts
+$17.4M
5
Goldman Sachs
Goldman Sachs
New York
+$8.7M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$107M
2
LCP
LGT Capital Partners
Switzerland
-$38.1M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$26.5M
4
Millennium Management
Millennium Management
New York
-$25.2M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$468M -$26.5M -330,212 -5%
BlackRock
2
BlackRock
New York
$462M +$26.9M +334,707 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$412M +$3.83M +47,641 +0.9%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$317M -$107M -1,331,646 -25%
Neuberger Berman Group
5
Neuberger Berman Group
New York
$305M -$1.6M -19,953 -0.5%
State Street
6
State Street
Massachusetts
$133M -$433K -5,389 -0.3%
Franklin Resources
7
Franklin Resources
California
$106M +$83.7K +1,041 +0.1%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$97M +$48.3M +600,554 +95%
Fisher Asset Management
9
Fisher Asset Management
Washington
$87M -$11.3M -140,846 -11%
Schroder Investment Management Group
10
Schroder Investment Management Group
United Kingdom
$75M -$2.41M -30,014 -3%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$71.6M +$1.98M +24,628 +3%
RA
12
Royce & Associates
New York
$64.9M -$3.97M -49,346 -6%
Northern Trust
13
Northern Trust
Illinois
$50.8M -$368K -4,576 -0.7%
Arrowstreet Capital
14
Arrowstreet Capital
Massachusetts
$49.3M +$36.5M +454,459 +263%
BTW
15
Boston Trust Walden
Massachusetts
$49.2M -$287K -3,569 -0.6%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$44.1M -$4.34M -54,019 -9%
Boston Partners
17
Boston Partners
Massachusetts
$41M +$17.4M +216,210 +72%
Charles Schwab
18
Charles Schwab
California
$39M -$874K -10,875 -2%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$38.2M +$6.39M +79,532 +20%
Ameriprise
20
Ameriprise
Minnesota
$35.1M -$589K -7,322 -2%
Norges Bank
21
Norges Bank
Norway
$33.9M +$3.34M +41,519 +11%
Millennium Management
22
Millennium Management
New York
$33.8M -$25.2M -313,408 -42%
Point72 Asset Management
23
Point72 Asset Management
Connecticut
$29.4M -$14.8M -183,693 -33%
HA
24
Heartland Advisors
Wisconsin
$27M -$5.51M -68,541 -17%
Westfield Capital Management
25
Westfield Capital Management
Massachusetts
$25.4M +$980K +12,188 +4%
1
2 3 4 5

HAE Hedge Fund Activity: Q4 2022 in Review

294 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q4 2022, worth a combined $3.9B — up 1.9% from $3.83B a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new HAE positions and 20 closed out — a net gain of 29 holders — while 103 added to existing stakes and 104 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $48.3M. The largest seller was Wellington Management Group, cutting an estimated $107M.

  • 294 institutional investors held Haemonetics (HAE) as of Q4 2022, up from 270 in Q3 2022.
  • Funds reported $3.9B of Haemonetics stock for Q4 2022, up 1.9% quarter-over-quarter.
  • 49 funds opened new Haemonetics positions in Q4 2022 and 20 closed out, a net change of +29 holders.
  • The largest Haemonetics buyer in Q4 2022 was Fidelity Investments, an estimated $48.3M added.
  • The largest Haemonetics seller in Q4 2022 was Wellington Management Group, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2022.